Byrne Asset Management LLC Humacyte, Inc. Transaction History

Byrne Asset Management LLC

  • $115 Million
  • Q4 2024

A detailed history of Byrne Asset Management LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Byrne Asset Management LLC holds 3,000 shares of HUMA stock, worth $10,620. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,000
Previous 3,000 -0.0%
Holding current value
$10,620
Previous $14,000 7.14%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024
BUY
$2.57 - $4.84 $2,570 - $4,840
1,000 Added 50.0%
3,000 $9,000
Q3 2023

Oct 31, 2023
BUY
$2.75 - $4.48 $5,500 - $8,960
2,000 New
2,000 $5,000

Others Institutions Holding HUMA

# of Institutions
172
Shares Held
41M
Call Options Held
553K
Put Options Held
942K
View Full List

About Humacyte, Inc.

HUMA Quotes by TradingView
  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $365M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Byrne Asset Management LLC Portfolio

Follow Byrne Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Byrne Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email